Business
Steriwave evaluation at major heart institute
Steriwave evaluation at major heart institute.
About this update from Ondine Biomedical, Inc.
[{"type":"text","content":"\n\n12 September 2023\nONDINE BIOMEDICAL INC.\n(\"Ondine Biomedical\", \"Ondine\" or the \"Company\") \nSteriwave evaluation at major heart institute\nCanadian life sciences company Ondine Biomedical Inc. (LON: OBI) has launched an eight-month evaluation of its Steriwave® nasal photodisinfection technology at the University of Alberta's Mazankowski Alberta Heart Institute in Edmonton, Canada, a world-leading centre for complex cardiac care and surgery. The evaluation will include around 1000 cardiac surgery patients treated with Steriwave to further reduce post-surgical infection risk.\nSurgical site infections (SSIs) are one of the most significant complications in cardiac surgery patients and are strongly associated with poorer prognosis, longer hospitalization, higher medical costs, and high mortality.[1] Universal pre-operative nasal decolonization has been found to significantly decrease SSIs caused by the infection-causing pathogen S. aureus following cardiac procedures.[2]\nOndine Biomedical's CEO Carolyn Cross said:\n\"Ondine is delighted to be working with one of the top cardiac healthcare facilities in the world to further reduce the risk of infections following cardiac surgery. The consequences of a post-surgical infection can be catastrophic and can be especially hard for a patient and their family if the procedure itself has been successful. The team at the Mazankowski Alberta Heart Institute has been fantastic and welcomed the addition of Steriwave nasal photodisinfection to their infection prevention protocols. We are very pleased to help and look forward to sharing results from this evaluation next year.\"\nOndine's nasal photodisinfection treatment kills all types of pathogens - viruses, bacteria, and fungi - in minutes without causing resistance and is already in use in major hospitals across Canada, including Vancouver General Hospital and The Ottawa Hospital.\nIn these hospital settings, pre-surgical use of Steriwave has resulted in significant improvement in post-surgical outcomes including lower rates of infection, reduced patient length of stay, fewer readmissions, and lower rates of antibiotic prescribing.[3],[4],[5] In Ondine's US Phase 2 trial, a single, five-minute nasal photodisinfection treatment was found to eliminate or significantly decrease Staphylococcus aureus (S. aureus) in 86% of carrier...